The FDA has accepted for Priority Review the Biologics License Application for veligrotug for the treatment of thyroid eye disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback